Stability has been replaced by volatility as stock market investors face elevated uncertainty ahead. Conflict in the Middle East is dominating the market mood, sparking oil price spikes and inflation worries.
Fragile economic signals, stock valuations, and policy unpredictability are additional balls for investors to juggle.
Markets remain volatile because:
- Investors lack clarity on central-bank policy
- Growth signals are weakening
- Geopolitical conflicts elevate risk
- Valuations (especially in tech/AI) look stretched
- Energy and supply-chain shocks persist
These pressures mean markets can rally on good news but remain vulnerable to sharp pullbacks.
History may not be an accurate guide to future performance but there are certainly valuable lessons to be learned from the past, not least, to invest through cycles rather than trying to time them.
So, what are the best stocks to buy in April with a medium-term horizon… say five years? To answer this question, we asked AI, or three of the leading AI engines; OpenAI’s ChatGPT, Microsoft’s Copilot and Google Gemini.
What we asked – ‘what are the best FTSE 350 stocks to buy in April for the next five years’
Here are the answers.
ChatGPT
🧠 Big picture (why FTSE 350 now?)
- UK equities are cheap vs global peers (lower P/E ratios)
- ~63% of analyst ratings are ‘buy’ — highest in over a decade
- Potential tailwinds: rate cuts, undervaluation, M&A interest
👉 Translation: This is more of a value + recovery + income market than a pure growth market.
🏆 Best FTSE 350 stocks (5-year outlook)
1) High-quality compounders (core holdings)
These are your ‘buy and forget’ names.
- London Stock Exchange (LSEG)
- Relx (REL)
- AstraZeneca (AZN)
💡 Why:
- Strong pricing power + recurring revenues
- Among most loved by analysts (up to 100% buy ratings)
- Global exposure (not just UK economy)
👉 If you only pick a few stocks → start here.
2) Growth industrials (under-the-radar winners)
From recent analyst lists:
- IMI (IMI)
- Spirax (SPX)
- Rotork (ROR)
- Bodycote (BOY)
💡 Why:
- Exposure to automation, energy transition, and infrastructure
- Analysts see ~15%–45% upside on some names
👉 These are classic ‘boring but powerful’ compounders.
3) UK recovery / domestic plays
More cyclical — higher upside, more risk.
- Bellway (BWY)
- Telecom Plus (TEP)
- Kier (KIE)
- Mitie (MTO)
💡 Why:
- Benefit from falling interest rates + UK economic recovery
- Some have been beaten down → valuation upside
👉 Best if you believe the UK economy improves by 2027–2028.
4) Financials & alternative assets (undervalued cash generators)
- 3i (III)
- Prudential (PRU)
- Beazley (BEZ)
💡 Why:
- Strong analyst support (90%+ buy ratings in some cases)
- Benefit from higher rates + global growth exposure
👉 Often overlooked but historically strong long-term performers.
5) Higher-risk / higher-upside picks
- Chemring (CHG)
- Volution (FAN)
- Elementis (ELM)
- Serica Energy (SQZ)
💡 Why:
- Some have 30%–45%+ upside forecasts
- Energy/defence tailwinds + re-rating potential
👉 Expect volatility — but strong returns if thesis plays out.
⚖️ Suggested 5-year portfolio mix
If you want a balanced approach:
- 40% → Compounders (LSEG, RELX, AZN)
- 25% → Industrials (IMI, SPX, ROR)
- 20% → Financials (III, PRU)
- 15% → Cyclical/high-risk plays
⚠️ Key risks (don’t ignore these)
- Geopolitics still driving volatility (recent FTSE dips)
- UK growth remains fragile
- Some ‘cheap’ stocks are cheap for a reason
🧾 Bottom line
For a 5-year horizon, the best FTSE 350 strategy isn’t chasing one winner — it’s:
👉 Anchor on global compounders (LSEG, RELX, AstraZeneca)
👉 Add industrials for growth
👉 Sprinkle in cyclicals for upside
Copilot
Below is a data‑driven, FTSE‑350‑focused list of some of the strongest UK large‑cap names that analysts, market data, and sector‑level fundamentals suggest could be compelling long‑term holdings (five‑year horizon) as of April 2026.
All picks are supported by current market‑cap leadership, sector strength, and analyst sentiment.
⭐ Best FTSE 350 Stocks to consider buying in April (5‑Year View)
The most reliable long‑term UK stocks tend to be those with:
- dominant global market positions
- strong cash flow and dividend track records
- structural sector tailwinds (healthcare, defence, energy transition, consumer staples)
- high analyst ‘buy’ ratings
A great starting point is the largest and most resilient FTSE 350 companies, as ranked by market cap as of 1 January 2026.
Below are the most compelling picks by sector, along with why they stand out for a five‑year horizon.
🧬 1. AstraZeneca (AZN) – Healthcare
Why it’s a strong 5‑year pick:
- UK’s largest FTSE 350 company by market cap ($284B).
- A global leader in oncology, respiratory, and immunology.
- Healthcare demand grows regardless of economic cycles, supporting long‑term earnings stability.
5‑year thesis: High‑innovation drug pipelines and expansion into rare diseases position it for sustained revenue growth.
🏦 2. HSBC (HSBA) – Banking & Financials
Why it stands out:
- Huge FTSE 350 constituent ($275bn).
- High analyst buy ratings entering 2026, with 63% buy recommendations across FTSE 350 financials.
- Beneficiary of global interest‑rate normalization, strong Asian exposure.
5‑year thesis: Interest‑rate volatility is easing, and HSBC’s scale plus dividends make it a defensive long‑term choice.
🛢️ 3. Shell (SHEL) – Energy / Transition
Why it’s compelling:
- Massive integrated energy group ($211bn).
- Strong cash generation enables buybacks and dividends.
- Investing heavily in LNG and low‑carbon energy.
5‑year thesis: Energy transition + hydrocarbons demand = durable cash flows.
🍽️ 4. Unilever (ULVR) – Consumer Staples
Why consider it:
- $141bn UK consumer‑staples powerhouse.
- Defensive earnings profile ideal in uncertain markets (Forbes highlights defensive stocks as best April buys).
- Long track record of dividends, global brands, and pricing power.
5‑year thesis: Stable long‑term compounder with consistent global demand.
✈️ 5. Rolls‑Royce (RR.) – Aerospace & Defence
Why it’s attractive:
- Huge FTSE 350 member ($132bn).
- Strong recovery in civil aerospace + defence spending surge globally.
- Shares have already posted strong gains in early 2026.
5‑year thesis: Engine service contracts + defence growth create multi‑year revenue visibility.
🔫 6. BAE Systems (BA.) – Defence
Why it stands out:
- A top‑20 FTSE 350 company.
- Up over 22% in 2026 already due to rising global defence spending.
5‑year thesis: Defence demand remains structurally high; order books are long and funded by governments.
🔋 7. Rio Tinto (RIO) – Metals & Mining
Why pick it:
- £131bn giant in industrial metals.
- Beneficiary of long‑term demand for copper, aluminium, lithium — all key to electrification.
- Up over 20% in 2026 already.
5‑year thesis: Mining majors produce high dividends + benefit from decarbonization commodity cycles.
🚬 8. British American Tobacco (BATS) – Consumer Staples / High Yield
Why it works long‑term:
- Large FTSE 350 constituent ($122bn).
- Historically high dividend yields and strong cash generation.
- Transitioning into reduced‑risk nicotine products.
5‑year thesis: A classic defensive stock with substantial yield for reinvestment‑driven growth.
💊 9. GSK (GSK) – Pharmaceuticals
Why it’s appealing:
- Strong FTSE 350 healthcare name ($99bn).
- Shares have jumped over 24% in early 2026.
- Strength in vaccines and specialty medicines.
5‑year thesis: Restructuring + focused R&D pipeline drives stable multi‑year expansion.
⚙️ 10. National Grid (NG.) – Utilities & Infrastructure
Why include it:
- Major FTSE 350 utility ($77bn).
- Up 20% so far in 2026.
- Critical operator in the UK energy‑transition infrastructure.
5‑year thesis: Regulated returns + electrification theme = steady, predictable compounding.
📌 Summary Table
| Stock | Sector | Why It Works for 5 Years |
| AstraZeneca | Healthcare | Global drug pipeline + secular demand |
| HSBC | Financials | High analyst buy ratings; rate‑cycle tailwinds |
| Shell | Energy | Strong cash flows; energy transition exposure |
| Unilever | Consumer Staples | Defensive, pricing power, stable dividends |
| Rolls‑Royce | Aerospace | Earnings recovery + defence tailwinds |
| BAE Systems | Defence | Strong 2026 gains; multi‑year defence budgets |
| Rio Tinto | Mining | Metals demand for electrification; strong start to 2026 |
| BAT | Staples | High yield + resilient cash flow |
| GSK | Healthcare | Strong early‑2026 performance; focused portfolio |
| National Grid | Utilities | Regulated returns; electrification infrastructure |
Gemini
For April 2026, analysts are notably bullish on the FTSE 350, with 63% of recommendations being ‘buys’. Experts highlight a mix of defensive income, structural growth, and value recovery plays for the next five years.
Top Growth & Transformation Picks
- Rolls-Royce (RR.): Transitioned from a recovery story to a structural growth leader. It benefits from long-term civil aerospace service contracts and rising global defence demand.
- Relx (REL): Favoured for its ‘structural growth’ in data analytics and information services. Recurring subscription revenues provide visibility for a 5-year horizon.
- 3i (III): High analyst popularity (90% buy rating). Its primary asset, Action, continues to see aggressive European store expansion.
Defensive & Quality Income
- Unilever (ULVR): Recommended for its resilience and simplified business model following recent spin-offs. It offers a balanced profile with over 50% of sales in emerging markets.
- AstraZeneca (AZN): The UK’s most valuable company with a dominant position in oncology and a strong drug pipeline for long-term revenue growth.
- Tesco (TSCO): Holds a 29% UK market share and is leveraging its scale to manage inflationary pressures.
Value & Cyclical Opportunities
- Barclays (BARC) / NatWest (NWG): Analysts see these as ‘cheap’ ways to gain exposure to an improving UK economy. NatWest is highlighted as a top sector replacement for income seekers due to its 5% yield.
- Shell (SHEL): Noted for financial discipline, consistent share buybacks, and a dual-track strategy in traditional hydrocarbons and renewable energy.
- Rightmove (RMV): Trading at a decade low, analysts view its recent price weakness as a buying opportunity for a business with high recurring revenue.
Summary of Sector Sentiment (2026 Outlook)
| Sector | Outlook | Key Drivers |
| Aerospace & Defence | Bullish | Rising NATO spending; civil aviation recovery |
| Banks | Positive | Undervalued multiples; beneficiaries of rate environment |
| Consumer Staples | Defensive | Pricing power and emerging market exposure |
| Pharmaceuticals | Strong | Aging global populations; innovative R&D pipelines |
You might also like:
